title: Response to Becher and Strohner comment regarding Baker DL et al. Evaluation of two commercial omalizumab/free IgE immunoassays: implications of use during therapy. CMRO 2014;30:913-22.
authors: Department of Assay Development and Technology Genentech , 1 DNA Way, South San Francisco CA 94080 , USA.
authors: Dana L
authors: DL
authors: Baker
authors: Kun
authors: K
authors: Peng
authors: Melissa
authors: M
authors: Cheu
authors: Saloumeh Kadkhodayan
authors: SK
authors: Fischer
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D001249:Asthma / Q000097:blood* / Q000188:drug therapy*; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D007073:Immunoglobulin E / Q000097:blood*
chemical_list: D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D007073:Immunoglobulin E